Monday, June 29, 2009
When research tool provider
Invitrogen Corp. acquired instrument company Applied Biosystems Group in 2008,
both companies derived the majority of their revenues from consumables.
However, Invitrogen's historical strengths lay in the sample preparation and
processing end of the laboratory workflow, while ABI's historical strengths lay
at the other end, in instrumentation and reagents optimized for its own
The merger's rationale was put to the test on April 23, when
Centers for Disease Control asked the now renamed Life Technologies Corp. for help tracking and monitoring the outbreak
of swine influenza. The agency had developed a swine influenza assay to run on
the company's real-time PCR instrument.